A pilot study of the diagnostic and prognostic values of FLT-PET/CT for pancreatic cancer: comparison with FDG-PET/CT

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Abdominal Radiology

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00261-016-0987-1PMID 27891549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 3′-Deoxy-3′-18F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer

  2015cited by this paper
• Prognostic Value Comparison Between 18F-FLT PET/CT and 18F-FDG PET/CT Volume-Based Metabolic Parameters in Patients with Head and Neck Cancer

  2015cited by this paper
• Prognostic Significance of Volume-Based FDG PET/CT Parameters in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation Therapy

  2014influential reference
• Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging.

  2014influential reference
• Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients with Pancreatic Cancer

  2014influential reference
• Metabolic tumour burden assessed by 18F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection

  2014influential reference
• Predictive Value of Maximum Standardized Uptake Value (SUVmax) on 18F-FDG PET/CT in Patients With Locally Advanced or Metastatic Pancreatic Cancer

  2013cited by this paper
• Prognostic Value of 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Resectable Pancreatic Cancer

  2013cited by this paper
• FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis.

  2013cited by this paper
• Diagnostic performance of 18F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with 18F-fluorodeoxyglucose PET/CT

  2013cited by this paper
• Comparison of 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours

  2012cited by this paper
• Clinical applications of 18F-FDG PET in the management of hepatobiliary and pancreatic tumors

  2012cited by this paper
• Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours

  2012cited by this paper
• Predictive Value of Initial 18F-FLT Uptake in Patients with Aggressive Non-Hodgkin Lymphoma Receiving R-CHOP Treatment

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Role of FDG-PET/CT in diagnosis, staging, response to treatment, and prognosis of pancreatic cancer.

  2011cited by this paper
• Usefulness of 18F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: a meta-analysis.

  2011cited by this paper
• 18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy.

  2010cited by this paper
• Phantom study on radiotherapy planning using PET/CT--delineation of GTV by evaluating SUV.

  2010cited by this paper
• From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

  2009cited by this paper
• Imaging of Cell Proliferation: Status and Prospects

  2008cited by this paper
• In Vivo Characterization of Proliferation for Discriminating Cancer from Pancreatic Pseudotumors

  2008cited by this paper
• A Multicenter Clinical Trial on the Diagnostic Value of Dual-Tracer PET/CT in Pulmonary Lesions Using 3′-Deoxy-3′-18F-Fluorothymidine and 18F-FDG

  2008cited by this paper
• Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F]fluorothymidine positron emission tomography

  2007cited by this paper
• Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

  2007cited by this paper
• Integrated PET/CT: current applications and future directions.

  2006cited by this paper
• Usefulness of 3′-[F-18]Fluoro-3′-deoxythymidine with Positron Emission Tomography in Predicting Breast Cancer Response to Therapy

  2005cited by this paper
• Pancreatic cancer

  2004cited by this paper
• [18F]FLT-PET in oncology: current status and opportunities

  2004cited by this paper
• Fully automated synthesis system of 3'-deoxy-3'-[18F]fluorothymidine.

  2004cited by this paper
• Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancer

  2003cited by this paper
• Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.

  2002cited by this paper
• Imaging proliferation in vivo with [F-18]FLT and positron emission tomography

  1998cited by this paper

• Predicting pathological response to neoadjuvant chemoradiotherapy in resectable and borderline resectable pancreatic ductal adenocarcinoma: a comparative study of 18F-FLT and 18F-FDG PET

  2025cites this paper
• Clinical value of PET/CT with carbon-11 4DST in the evaluation of malignant and benign lung tumors

  2021cites this paper
• Clinical Impact of 18F-FDG PET/CT in the Diagnostic Workup of Pancreatic Ductal Adenocarcinoma: A Systematic Review

  2020influential citation
• F-Fluorodeoxyglucose Positron Emission Tomography Predicts Treatment Efficacy and Clinical Outcome for Patients With Pancreatic Carcinoma

  2019cites this paper
• A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery

  2017cites this paper